SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE

<p>Background. Older population has more symptoms and disease signs as elderly people are more prone to ilnesses. That is why they take both prescribed and unprescribed drugs more frequently. In 2003 Slovenian insured persons younger than 65 received on average 5.5 prescriptions while those ab...

Full description

Bibliographic Details
Main Author: Jože Drinovec
Format: Article
Language:English
Published: Slovenian Medical Association 2004-10-01
Series:Zdravniški Vestnik
Subjects:
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/2364
id doaj-c356ef7a8d29460d8dad21257d696e9a
record_format Article
spelling doaj-c356ef7a8d29460d8dad21257d696e9a2020-11-24T22:53:40ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242004-10-0173101835SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGEJože Drinovec0Krka d.d. Novo mesto Dunajska 65 1000 Ljubljana<p>Background. Older population has more symptoms and disease signs as elderly people are more prone to ilnesses. That is why they take both prescribed and unprescribed drugs more frequently. In 2003 Slovenian insured persons younger than 65 received on average 5.5 prescriptions while those above 65 received 19.4 prescriptions. During the same year 4,811 insured persons received a prescription for 10 drugs and 160 of them for 18 or more drugs.</p><p>There are many physiological changes that accompany aging and are important for pharmacotherapy. For example, body fat increases while total body water, plasma volume and serum albumin concentration decrease. There is also a significant decrease of kidney function, most notably seen in glomerular filtration rate.</p><p>Conclusions. Basic recommendations for pharmacotherapy in old age include a decrease in simultaneous drug consumation, if possible to the value of 4. Recommended dose for majority of drugs would be 1/2 to 2/3 of the one taken by a man of average age having an average body mass.<br /><br /></p>http://vestnik.szd.si/index.php/ZdravVest/article/view/2364pharmacotherapydrugsold agepolymorbiditypolypharmacotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Jože Drinovec
spellingShingle Jože Drinovec
SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE
Zdravniški Vestnik
pharmacotherapy
drugs
old age
polymorbidity
polypharmacotherapy
author_facet Jože Drinovec
author_sort Jože Drinovec
title SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE
title_short SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE
title_full SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE
title_fullStr SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE
title_full_unstemmed SOCIAL AND CLINICAL ASPECTS OF PHARMACOTHERAPY IN OLD AGE
title_sort social and clinical aspects of pharmacotherapy in old age
publisher Slovenian Medical Association
series Zdravniški Vestnik
issn 1318-0347
1581-0224
publishDate 2004-10-01
description <p>Background. Older population has more symptoms and disease signs as elderly people are more prone to ilnesses. That is why they take both prescribed and unprescribed drugs more frequently. In 2003 Slovenian insured persons younger than 65 received on average 5.5 prescriptions while those above 65 received 19.4 prescriptions. During the same year 4,811 insured persons received a prescription for 10 drugs and 160 of them for 18 or more drugs.</p><p>There are many physiological changes that accompany aging and are important for pharmacotherapy. For example, body fat increases while total body water, plasma volume and serum albumin concentration decrease. There is also a significant decrease of kidney function, most notably seen in glomerular filtration rate.</p><p>Conclusions. Basic recommendations for pharmacotherapy in old age include a decrease in simultaneous drug consumation, if possible to the value of 4. Recommended dose for majority of drugs would be 1/2 to 2/3 of the one taken by a man of average age having an average body mass.<br /><br /></p>
topic pharmacotherapy
drugs
old age
polymorbidity
polypharmacotherapy
url http://vestnik.szd.si/index.php/ZdravVest/article/view/2364
work_keys_str_mv AT jozedrinovec socialandclinicalaspectsofpharmacotherapyinoldage
_version_ 1725662489815810048